Aurora Cannabis: 'Astonishing that CanniMed has not responded to bid'
Aurora Cannabis is still in hot pursuit of CanniMed Therapeutics. After an unsolicited offer with no response, Cam Battley, executive vice president with Aurora Cannabis, says the company will move forward with a formal offer. We hear about this and the acquisition of Larssen on Commodities.